200 related articles for article (PubMed ID: 34328485)
1. Interplay between nanomedicine and protein corona.
Yang M; Wu E; Tang W; Qian J; Zhan C
J Mater Chem B; 2021 Sep; 9(34):6713-6727. PubMed ID: 34328485
[TBL] [Abstract][Full Text] [Related]
2. Formation of the Protein Corona: The Interface between Nanoparticles and the Immune System.
Barbero F; Russo L; Vitali M; Piella J; Salvo I; Borrajo ML; Busquets-Fité M; Grandori R; Bastús NG; Casals E; Puntes V
Semin Immunol; 2017 Dec; 34():52-60. PubMed ID: 29066063
[TBL] [Abstract][Full Text] [Related]
3. The Crown and the Scepter: Roles of the Protein Corona in Nanomedicine.
Cai R; Chen C
Adv Mater; 2019 Nov; 31(45):e1805740. PubMed ID: 30589115
[TBL] [Abstract][Full Text] [Related]
4. Improving dispersal of therapeutic nanoparticles in the human body.
Limongi T; Canta M; Racca L; Ancona A; Tritta S; Vighetto V; Cauda V
Nanomedicine (Lond); 2019 Apr; 14(7):797-801. PubMed ID: 30895871
[No Abstract] [Full Text] [Related]
5. Research progress and application opportunities of nanoparticle-protein corona complexes.
Huang W; Xiao G; Zhang Y; Min W
Biomed Pharmacother; 2021 Jul; 139():111541. PubMed ID: 33848776
[TBL] [Abstract][Full Text] [Related]
6. The biomolecular corona of nanomedicines: effects on nanomedicine outcomes and emerging opportunities.
Salvati A
Curr Opin Biotechnol; 2024 Jun; 87():103101. PubMed ID: 38461749
[TBL] [Abstract][Full Text] [Related]
7. Effect of protein corona magnetite nanoparticles derived from bread in vitro digestion on Caco-2 cells morphology and uptake.
Di Silvio D; Rigby N; Bajka B; Mackie A; Baldelli Bombelli F
Int J Biochem Cell Biol; 2016 Jun; 75():212-22. PubMed ID: 26520468
[TBL] [Abstract][Full Text] [Related]
8. Protein bio-corona: critical issue in immune nanotoxicology.
Neagu M; Piperigkou Z; Karamanou K; Engin AB; Docea AO; Constantin C; Negrei C; Nikitovic D; Tsatsakis A
Arch Toxicol; 2017 Mar; 91(3):1031-1048. PubMed ID: 27438349
[TBL] [Abstract][Full Text] [Related]
9. The nanoparticle protein corona formed in human blood or human blood fractions.
Lundqvist M; Augustsson C; Lilja M; Lundkvist K; Dahlbäck B; Linse S; Cedervall T
PLoS One; 2017; 12(4):e0175871. PubMed ID: 28414772
[TBL] [Abstract][Full Text] [Related]
10. Nano-Bio Interactions in Cancer: From Therapeutics Delivery to Early Detection.
Liu Y; Wang J; Xiong Q; Hornburg D; Tao W; Farokhzad OC
Acc Chem Res; 2021 Jan; 54(2):291-301. PubMed ID: 33180454
[TBL] [Abstract][Full Text] [Related]
11. How protein coronas determine the fate of engineered nanoparticles in biological environment.
Capjak I; Goreta SŠ; Jurašin DD; Vrček IV
Arh Hig Rada Toksikol; 2017 Dec; 68(4):245-253. PubMed ID: 29337683
[TBL] [Abstract][Full Text] [Related]
12. Protein corona: challenges and opportunities for targeted delivery of nanomedicines.
Jiang Z; Chu Y; Zhan C
Expert Opin Drug Deliv; 2022 Jul; 19(7):833-846. PubMed ID: 35738018
[TBL] [Abstract][Full Text] [Related]
13. Protein Nanoparticle Charge and Hydrophobicity Govern Protein Corona and Macrophage Uptake.
Pustulka SM; Ling K; Pish SL; Champion JA
ACS Appl Mater Interfaces; 2020 Oct; 12(43):48284-48295. PubMed ID: 33054178
[TBL] [Abstract][Full Text] [Related]
14. Pay Attention to Biological Nanoparticles when Studying the Protein Corona on Nanomedicines.
Simonsen JB; Münter R
Angew Chem Int Ed Engl; 2020 Jul; 59(31):12584-12588. PubMed ID: 32347625
[TBL] [Abstract][Full Text] [Related]
15. The curious cases of nanoparticle induced amyloidosis during protein corona formation and anti-amyloidogenic nanomaterials: Paradox or prejudice?
Randhawa S; Abidi SMS; Dar AI; Acharya A
Int J Biol Macromol; 2021 Dec; 193(Pt A):1009-1020. PubMed ID: 34728302
[TBL] [Abstract][Full Text] [Related]
16. Exploiting the novel properties of protein coronas: emerging applications in nanomedicine.
Hamad-Schifferli K
Nanomedicine (Lond); 2015 May; 10(10):1663-74. PubMed ID: 26008198
[TBL] [Abstract][Full Text] [Related]
17. Protein Corona-Enabled Systemic Delivery and Targeting of Nanoparticles.
Chen D; Ganesh S; Wang W; Amiji M
AAPS J; 2020 Jun; 22(4):83. PubMed ID: 32495039
[TBL] [Abstract][Full Text] [Related]
18. Potential clinical applications of the personalized, disease-specific protein corona on nanoparticles.
García Vence M; Chantada-Vázquez MDP; Vázquez-Estévez S; Manuel Cameselle-Teijeiro J; Bravo SB; Núñez C
Clin Chim Acta; 2020 Feb; 501():102-111. PubMed ID: 31678275
[TBL] [Abstract][Full Text] [Related]
19. Dynamic Protein Corona of Gold Nanoparticles with an Evolving Morphology.
Nandakumar A; Wei W; Siddiqui G; Tang H; Li Y; Kakinen A; Wan X; Koppel K; Lin S; Davis TP; Leong DT; Creek DJ; Ding F; Song Y; Ke PC
ACS Appl Mater Interfaces; 2021 Dec; 13(48):58238-58251. PubMed ID: 34797630
[TBL] [Abstract][Full Text] [Related]
20. Chemical and Biophysical Signatures of the Protein Corona in Nanomedicine.
Ren J; Andrikopoulos N; Velonia K; Tang H; Cai R; Ding F; Ke PC; Chen C
J Am Chem Soc; 2022 Jun; 144(21):9184-9205. PubMed ID: 35536591
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
